Literature DB >> 3459810

Tourette syndrome: successful treatment with clonidine and oxycodone.

R Sandyk.   

Abstract

A 15-year-old boy with Tourette's syndrome exhibited severe involuntary self-mutilatory behavior. While clonidine effectively controlled the motor and phonic tics, it failed to ameliorate the self-mutilatory behavior. Administration of oxycodone (50 mg/day) combined with clonidine produced a dramatic reduction in the frequency and severity of the self-mutilatory acts within 12 h. This report indicates that disturbances in the functional interplay between the noradrenergic and opiatergic systems may be important in the pathophysiology of Tourette's syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3459810     DOI: 10.1007/BF00314429

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Naloxone withdrawal exacerbates Tourette syndrome.

Authors:  R Sandyk
Journal:  J Clin Psychopharmacol       Date:  1986-02       Impact factor: 3.153

2.  Tourette syndrome and the opioid system.

Authors:  M A Gillman; R Sandyk
Journal:  Psychiatry Res       Date:  1985-06       Impact factor: 3.222

3.  The effects of naloxone in Tourette's syndrome.

Authors:  R Sandyk
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

4.  Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors.

Authors:  G K Aghajanian
Journal:  J Clin Psychiatry       Date:  1982-06       Impact factor: 4.384

Review 5.  Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.

Authors:  J F Leckman; D J Cohen
Journal:  Psychiatr Dev       Date:  1983

6.  The epidemiology of Tourette's syndrome: a pilot study.

Authors:  J Jagger; B A Prusoff; D J Cohen; K K Kidd; C M Carbonari; K John
Journal:  Schizophr Bull       Date:  1982       Impact factor: 9.306

7.  The primate locus coeruleus and effects of clonidine on opiate withdrawal.

Authors:  D E Redmond; Y H Huang
Journal:  J Clin Psychiatry       Date:  1982-06       Impact factor: 4.384

8.  Clonidine in Tourette's syndrome.

Authors:  D J Cohen; J G Young; J A Nathanson; B A Shaywitz
Journal:  Lancet       Date:  1979-09-15       Impact factor: 79.321

  8 in total
  4 in total

Review 1.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

Authors:  M Olga Rojas-Corrales; Juan Gibert-Rahola; Juan A Mico
Journal:  Psychopharmacology (Berl)       Date:  2006-11-11       Impact factor: 4.530

3.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

4.  The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study.

Authors:  Pan-Pan Song; Li Jiang; Xiu-Juan Li; Si-Qi Hong; Shuang-Zi Li; Yue Hu
Journal:  Front Neurol       Date:  2017-02-23       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.